AR011610A1 - USE OF 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2-PIRIDINYL] -PIPERACINE OR A PHARMACEUTICALLY ACCEPTABLE ADDITIONAL SALT OF THE SAME, A PHARMACEUTICAL FORMULATION ADAPTED FOR THE TREATMENT OF URINARY INCONTINENCE AND AN URINARY FORMULINATION WHICH INCLUDE SUCH A COMPOUND OR - Google Patents
USE OF 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2-PIRIDINYL] -PIPERACINE OR A PHARMACEUTICALLY ACCEPTABLE ADDITIONAL SALT OF THE SAME, A PHARMACEUTICAL FORMULATION ADAPTED FOR THE TREATMENT OF URINARY INCONTINENCE AND AN URINARY FORMULINATION WHICH INCLUDE SUCH A COMPOUND ORInfo
- Publication number
- AR011610A1 AR011610A1 ARP980100446A AR011610A1 AR 011610 A1 AR011610 A1 AR 011610A1 AR P980100446 A ARP980100446 A AR P980100446A AR 011610 A1 AR011610 A1 AR 011610A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutically acceptable
- urinary
- urinary incontinence
- treatment
- pharmaceutical formulation
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Uso de 1-[6-cloro-5-(trifluorometil)-2-piridinil]-piperacina, o una sal de adicion ácida farmacéuticamente aceptable de la misma, donde dicha1-[6-cloro-5-(trifluorometil)-2-piridinil)-2-]-piperacina, o una sal de adicion ácida farmacéuticamente aceptable de la misma es empleada para laelaboracion de un medicamento para el tratamiento o la profilaxis de la incontinencia urinaria. Un método para tratar la incontinencia urinaria enun animal que comprende el tratarlo con una cantidad terapéuticamente efectiva de 1-[-6-cloro-5-(trifluorometil)-2-piridinil]-piperacina, o una salde adicion ácida farmacéuticamente aceptable de la misma. Una formulacion farmacéutica adaptada para el tratamiento de la incontinenciaurinaria, quecomprende 1-[6-cloro-5-(trifluorometil)-2-piridinil]-piperacina, o una sal de adicion ácida farmacéuticamente aceptable de la misma, junto con underivado farmacéuticamente aceptable de la misma. Una formulacion anti- incontinencia urinaria, que comprende 1-[6-cloro-5-(trifluorometil)-2-piridinil]-piperacina, o una sal de adicion ácida de la misma farmacéuticamente aceptable, junto con un derivado farmacéuticamente aceptable para eso.Use of 1- [6-chloro-5- (trifluoromethyl) -2-pyridinyl] -piperazine, or a pharmaceutically acceptable acid addition salt thereof, wherein said 1- [6-chloro-5- (trifluoromethyl) -2- pyridinyl) -2 -] - piperazine, or a pharmaceutically acceptable acid addition salt thereof, is used for the manufacture of a medicament for the treatment or prophylaxis of urinary incontinence. A method of treating urinary incontinence in an animal comprising treating it with a therapeutically effective amount of 1 - [- 6-chloro-5- (trifluoromethyl) -2-pyridinyl] -piperazine, or a pharmaceutically acceptable acid addition salt thereof . A pharmaceutical formulation adapted for the treatment of urinary incontinence, comprising 1- [6-chloro-5- (trifluoromethyl) -2-pyridinyl] -piperazine, or a pharmaceutically acceptable acid addition salt thereof, together with pharmaceutically acceptable underivative of the same. A urinary incontinence formulation, comprising 1- [6-chloro-5- (trifluoromethyl) -2-pyridinyl] -piperazine, or a pharmaceutically acceptable acid addition salt thereof, together with a pharmaceutically acceptable derivative therefor.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97200285 | 1997-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011610A1 true AR011610A1 (en) | 2000-08-30 |
Family
ID=8227979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980100446 AR011610A1 (en) | 1997-02-03 | 1998-02-02 | USE OF 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2-PIRIDINYL] -PIPERACINE OR A PHARMACEUTICALLY ACCEPTABLE ADDITIONAL SALT OF THE SAME, A PHARMACEUTICAL FORMULATION ADAPTED FOR THE TREATMENT OF URINARY INCONTINENCE AND AN URINARY FORMULINATION WHICH INCLUDE SUCH A COMPOUND OR |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR011610A1 (en) |
| AU (1) | AU6619398A (en) |
| IL (1) | IL122975A0 (en) |
| ZA (1) | ZA98531B (en) |
-
1998
- 1998-01-19 IL IL12297598A patent/IL122975A0/en unknown
- 1998-01-22 ZA ZA98531A patent/ZA98531B/en unknown
- 1998-01-30 AU AU66193/98A patent/AU6619398A/en not_active Abandoned
- 1998-02-02 AR ARP980100446 patent/AR011610A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL122975A0 (en) | 1998-08-16 |
| ZA98531B (en) | 1998-07-17 |
| AU6619398A (en) | 1998-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69521994D1 (en) | COMPOSITIONS WHICH CONTAIN DNA DESTROYING AGENTS AND P53 | |
| RU2009112207A (en) | SPECIFIC GLUCCORTICOSTEROID COMPOUND WITH ANTI-INFLAMMATORY ACTIVITY | |
| GB2303629B (en) | Hydroxamic acids and their use as metalloproteinase inhibitors | |
| SE9301489D0 (en) | VETERINARY COMPOSITION | |
| ES2081780T3 (en) | NEW ARILPROPIONIC DERIVATIVE, PROCEDURE FOR ITS PREPARATION AND ITS USE AS AN ANALGESIC AGENT. | |
| BRPI0113331B8 (en) | phenylalanine derivatives or their pharmaceutically acceptable salts, alpha 4 integrin antagonist, therapeutic agent or preventive agent for inflammatory diseases, and pharmaceutical composition | |
| UY26372A1 (en) | "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM" | |
| BR0210122A (en) | Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same | |
| DE69932939D1 (en) | FULVIC ACID AND ITS USE FOR THE TREATMENT OF VARIOUS DISEASE STATES | |
| ATE333896T1 (en) | VASCULARIZATION INHIBITORS | |
| MXPA05003253A (en) | Novel pyrimidineamide derivatives and the use thereof. | |
| BR0316458A (en) | Compound, pharmaceutical composition, method of treating or preventing disease, method for enhancing cognition in a healthy patient, and use of a compound | |
| AU2002231889A1 (en) | Halogenated composition, method for preparing same and uses thereof | |
| SE9704644D0 (en) | New use | |
| NO994165L (en) | Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness | |
| AR015966A1 (en) | USE OF A PDE4 INHIBITOR COMPOUND FOR THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR PRURITE TREATMENT | |
| SE9603725D0 (en) | New teatment | |
| CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| EA199800717A1 (en) | METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION | |
| BR0007452A (en) | Use of melagatran or a pharmaceutically acceptable derivative or prodrug thereof, method of treating inflammation, and, pharmaceutical formulation for use in treating inflammation | |
| NO20042758L (en) | Procedure for treating a patient requiring analgesia. | |
| AU1656997A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
| AR011610A1 (en) | USE OF 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2-PIRIDINYL] -PIPERACINE OR A PHARMACEUTICALLY ACCEPTABLE ADDITIONAL SALT OF THE SAME, A PHARMACEUTICAL FORMULATION ADAPTED FOR THE TREATMENT OF URINARY INCONTINENCE AND AN URINARY FORMULINATION WHICH INCLUDE SUCH A COMPOUND OR | |
| PA8519501A1 (en) | FARNESIL TRANSFER INHIBITOR OF THE 1,2-RING QUINOLINE DUMPER | |
| BR0017367A (en) | Use of melagatran or a pharmaceutically acceptable derivative thereof, method of treating an ischemic disorder in a patient having, or at risk for, nonvalvular atrial fibrillation and pharmaceutical formulation |